GLP-1 and Weight-Loss Drugs: The Next Big Opportunity for PCD Franchise Owners
The pharmaceutical industry is witnessing growing interest in medicines in the area of metabolism and weight loss. Scott Morrison is a recognised pharmaceutical company that offers PCD pharma franchise opportunities in India to help entrepreneurs start and expand their pharmaceutical businesses in different areas. One of the upcoming sectors is the one of GLP-1 medications, which became widely popular in the treatment of type 2 diabetes and, for some approved drugs and indications, obesity/overweight. This evolving segment can be considered a great future potential for PCD franchise owners. What Are GLP-1 and Weight-Loss Drugs? GLP-1 (Glucagon-like Peptide-1) is a naturally occurring hormone that is involved in blood glucose regulation and appetite control. The GLP-1 receptor agonists have similar properties to that of GLP-1 such as increased glucose-dependent insulin secretion and reduced glucagon release secretion and slowing gastric emptying. Some newer medicines targeting the...